# Human Aging and in Vivo Noradrenergic System

> **NCT03942289** · NA · UNKNOWN · sponsor: **Hospices Civils de Lyon** · enrollment: 135 (estimated)

## Conditions studied

- Parkinson Disease

## Interventions

- **OTHER:** The role of the noradrenergic system across the life span (Healthy Subjects)
- **OTHER:** The role of the noradrenergic system across the life span (Parkinson's Disease Subjects)

## Key facts

- **NCT ID:** NCT03942289
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-04-29
- **Primary completion:** 2021-06-29
- **Final completion:** 2021-06-29
- **Target enrollment:** 135 (ESTIMATED)
- **Last updated:** 2019-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03942289

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03942289, "Human Aging and in Vivo Noradrenergic System". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03942289. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*